10th Australasian Viral Hepatitis Conference 2016
 

                                                                        Poster Listing


Poster Number
Title of Presentation First Name Last Name

Clinical Care
1 An Immunochromatographic Test for Measurement of Alanine Aminotransferase (ALT) at Point of Care David
Anderson
2 Fibroscan Screening in General Practice: Results from a Pilot Program David
Baker
3 Real Life Experience of Prescribing Direct Acting Agents (DAA’s) In a Primary Care Based General Practitioner Liver Clinic in Rural NSW - Does It Work?
Anne
Balcomb
4 Introduction of an Australian First Multidisciplinary Approach to the Initiation of Direct Acting Antivirals Involving Pharmacist Led Medication Reviews Millicent
Ballancin
5 Hepatitis C Specialist Social Worker in a Community Clinic: One of a Kind in New Zealand Marilyn Brown
6 APRI versus Fibroscan Score for Assessing Advanced Liver Diseases in a Communty-Based Cohort with Chronic HCV Infection Joseph
Doyle
7 Eliminating Hepatitis C Transmission by Enhancing Care and Treatment among HIV Co-Infected Individuals: The Co-EC Study  Joseph
Doyle
8 Incorporating Overdose Management into Routine Care of People who Inject Drugs who are Undergoing Hepatitis C Treatment with direct Acting Antivirals
 Rosie  Gilliver 
9 Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients with Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Jason
Grebely
10 Ledipasvir/Sofosbuvir for 8 Weeks – A Comparative Analysis of Clinical Trial Efficacy versus Real World Effectiveness
Krispin
Hajkowicz
11 Sofosbuvir/Velpatasvir for 12 Weeks Results In High Svr12 Rates in Subjects with Negative Predictors of Response to Treatment
Barbara Leggett
12 Hepatitis C Treatment Uptake in a Single Tertiary Based Viral Hepatitis Service Following Availability of Interferon-Free Treatments Gail    Matthews
13 A Nurse-Led Model of Care for Prisoners with Viral Hepatitis: Experience from the Victorian Statewide Hepatitis Program
Lucy McDonald
14 Treating Patients with Hepatitis C Genotype 1 Using Viekira Pak™ in the “Real World” – An Australian Nursing Perspective Saroj Nazareth
15 Hepatitis C Virus Infection: Barriers to Achieving Treatment Leigh-Anne
Pokino
16 Development of the Australasian Hepatology Association’s Consensus Guidelines for the Provision of Adherence Support to People with Hepatitis C Taking Direct Acting Antivirals
Jacqui Richmond
17 High SVR Rates with ABT-493 + ABT-530 Co-Administered for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 3 Infection Simone Strasser
18 Training of Health Professionals Working In Primary Care for the Active Search for Patients with Hepatitis C and Early Diagnosis Adauto
Vieira de Almeida
19 Hepatitis B Vaccination Status among Physical Therapy and Pharmacology Graduate Students
Adauto
Vieira de Almeida
20 Preliminary Data from the Prime Study; A Randomised Controlled Trial of Community Vs Hospital Direct Acting Antiviral Therapy Amanda
Wade
21 New Frontiers for Hepatitis C Treatment: Exploring the “In Consultation” Experience
Sally
Watkinson
22 Early Local Western Australian Experience with Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir +/- Ribavirin in Genotype 1 Hepatitis C Patients and its Impact on Liver Fibrosis and Liver Inflammation John   Wong
23 Scaling up Hepatitis Treatment in the NSW Custodial Setting – Challenges and Opportunities James    Wood

Epidemiology, Public Health and Prevention 

24 Hepatitis B contact tracing: what works Thalia Ash
25 Hepatitis C Risk Behaviour among People Who Inject Pharmaceutical Opioids
Louise
Geddes
26 Chronic Hepatitis C Burden and Care Cascade in Australia in the Era of Interferon-Based Treatment
Behzad
Hajari
27 Mums to B: Care for Women with Hepatitis B
Aurora
Tang
28 HepCheck 1-2-3: Integrated Hepatitis Care for People Affected by Homelessness
Kyle
Leadbeatter
29 Depression and its Association with Hepatitis B Status: Findings from 0.5 Million Chinese Adults
Uling
Liu
30 Training of Community Health Agents for Active Search of Patients with Viral Hepatitis
Flavia
Paro
31 Hepatitis B Vaccination among Primary Health Care Workers in a City of Brazil
Flavia
Paro
32 Knowledge about Viral Hepatitis among Primary Health Care Workers in Brazil 
Flavia
Paro
33 Epidemiological Profile of Organ Donors for Transplantation in Hospitals of Brazil
Flavia
Paro
34 Identifying the Essential Components of a Public Health Response to Hepatitis B: Tasmania
Jack Wallace
35 Survival Following Hepatocellular Carcinoma among People with a HBV or HCV Notification in New South Wales, Australia between 2000 and 2014
Reem
Waziry

Community and Social Research 
36 Increasing Access to Training for Regional NSP Workers: NSP Online Orientation and Training Package Judith
Bevan
37 Let us Build Bridges and Dismantle Inequitable Health Practices
Bronwyn
Briggs
38 Being Strong: Hepatitis, Liver Health and the NSW Corrective Services Intranet
Grace
Crowley
39 A Qualitative Study of the Perceptions of Interferon-Free Therapy for Hepatitis C Virus Infection among People who Inject Drugs: The Liverlife Study
Evan Cunningham
40 Viral Hepatitis in the Media: The Potential Negative Effects of Poor Reporting
Yvonne
Drazic
41 CHAT in Action Creating Change
Jaye
Hinchliffe
42 Health Promotion with Australian Afghan Community; How Building Relationships with Community Groups Assists with Health Promotion Activities
Sayed Jawid
43 Fostering A Vibrant Peer Workforce
Kyle
Leadbeatter
44 The Hepatitis Infoline: Community-Led and Community-Leading Developments in the Viral Hepatitis Community
Kyle
Leadbeatter
45 Is there a Need for Hepatitis-Informed Counselling in the Era of New DAA Treatments?
Kyle
Leadbeatter
46 The Success of Hepatitis B Campaign Within Africans/ Cultural and Linguistic Diverse (CALD) Living In South Australia
Martin
Manariyo
47 Eliminating Hepatitis C in the Australian Bleeding Disorders Population: An Evolving Health Promotion Strategy
Suzanne
O'Callaghan
48 Advocates in action: The work of Hepatitis Victoria Community Advocates 
Ross
Nafisa
Williams
Yuusf
49 Art inside the West: Collaborating With People in Custody
Gary Irving 

Basic Science
50 Modelling the Effects of Targeted DAA Hepatitis C Virus Treatment Strategies Using a Molecular Transmission Network of People with Recent Infection
Sofia
Bartlett
51 HBV Core Promoter Mutants Activate Pi3k/AKT Signalling In Cell Culture, Promoting Hepatocarcinogenesis
Anis
Khan
52 Hepatitis C Virus Core Antigen and Dried Blood Spots as Simplified Hepatitis C Virus Diagnostic Tools
Francois
Lamoury
53 Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool among those with Recent HCV Infection, Including for Post-Treatment Relapse
Francois
Lamoury
54 Deep Sequencing Shows that the Presence Of HBV BCP/Pc Variants Reduces the Rate of HBSAG Loss among HBEAG-Positive CHB Patients Treated with Long-Term Tenofovir DF Therapy
Margaret
Littlejohn
55 Refolding the Hepatitis C Virus E2 Glycoprotein to Enhance Immunogenicity
Lilian
Phu
56 Commitment to CD8+ T Cell Exhaustion and Loss of Memory T Cell Potential Develops during Primary Chronic HCV Infection
Mehdi
Rasoli Pirozyan
57 Trends of Hepatitis C Virus Epidemic in Australia and North America in 20th Century: Back Projections from Molecular Epidemiology
Chaturaka
Rodrigo
58 Viral Kinetic are Significantly Different In Basal Core Promoter and Precore Variants of Hepatitis B
Zina
Valaydon
59 Triterpenoid Saponin from Wedelia Calendulacea Protects against Ccl4 Induced Liver Injury by Inhibiting Nf-Κb Activation
Amita
Verma